Dalteparin sodium
Fragmin (dalteparin sodium) is a low-molecular-weight heparin anticoagulant used to prevent and treat blood clots, such as deep vein thrombosis. It's administered as a subcutaneous injection and is available in various strengths. Manufactured by Pfizer Laboratories Div Pfizer Inc. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Fragmin (dalteparin sodium) is a low-molecular-weight heparin anticoagulant used to prevent and treat blood clots, such as deep vein thrombosis. It's administered as a subcutaneous injection and is available in various strengths. Manufactured by Pfizer Laboratories Div Pfizer Inc. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Dalteparin sodium",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Dalteparin sodium — ANDA 020287 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020287"
}
]
|
| identifier | ANDA020287 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-information",
"drug-manufacturers",
"drug-safety",
"medications"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Dalteparin sodium |
